Analysis: Emmvee Photovoltaic Power Ltd

What does Emmvee Photovoltaic Power Ltd do?

• Emmvee Photovoltaic Power Ltd is a vertically integrated manufacturer of solar photovoltaic cells and modules, headquartered in Bengaluru, India.
• The company operates as a leading player in India's renewable energy sector, with a focus on TopCon technology for high-efficiency solar cells.
• Emmvee has commissioned 10.3 GW of module capacity and 2.94 GW of cell capacity as of Q3FY26, with plans to expand further.

• Core operations include manufacturing of monocrystalline and TopCon solar cells and modules.
• Serves domestic developers and large account customers, with a 4.5 GW multi-year TopCon cell order secured.
• Exports and domestic sales are balanced, with pass-through contracts for raw material cost management.

Growth thesis

Emmvee Photovoltaic Power Ltd is an integrated Indian solar manufacturer producing TOPCon cells and modules for utility-scale IPPs, commercial and industrial customers, rooftop installers and government-backed DCR schemes. It operates 10.3 GW of module capacity and 2.94 GW of cell capacity, with a 6 GW integrated expansion intended to lift this to 16.3 GW of modules and 8.9 GW of cells after the module line in December 2026 and the cell line in March 2027. The business is no longer a module assembler: cell production began in September 2024, and the in-house cell line is now the main determinant of group margin and capital intensity.

Q2 FY27 showed the operating model at scale. Revenue from operations was INR 1,576 crore, up 39% year-on-year, EBITDA was INR 557 crore with a 35.3% margin, and PAT was INR 382 crore, up 61%. H1 FY27 revenue was INR 3,132 crore, up 45%, EBITDA INR 1,105 crore, up 47%, and PAT INR 762 crore, up 79%. Finance cost fell to about INR 9.5 crore in Q2 FY27 from INR 55.2 crore a year earlier after the IPO-funded debt repayment, while H1 operating cash generation rose to about INR 410 crore from INR 121 crore. Net debt to equity was 0.12x at 30 September 2026. These are reported results, not annualised projections.

The economics rest on integration and mix. Management guides EBITDA per watt of about INR 2-2.5 for non-DCR modules, INR 6.0-6.5 for cells, and INR 8.5-9 for DCR modules. DCR modules carry the highest spread because they must use domestically made cells, and domestic TOPCon cell supply is tight. DCR sales were over 50% in both Q1 and Q2 FY27, and the end-Q2 order book was about 70% DCR and 30% non-DCR. About 25% of module sales were retail and KUSUM, 75% institutional C&I and IPP, and open-access C&I was 40-45% of Q2 order inflow. That mix supports the blended margin, but it also makes policy execution and customer concentration central to the thesis.

Cell utilisation is the clearest operating proof. Effective utilisation rose from 83% in Q1 FY27 to 89% in Q2 FY27, and management expects close to 90% for the remaining two quarters. More than 50% of cell capacity has converted to G12R, with the remainder to follow after M10 orders. Module utilisation was 44% in Q2 FY27, and management guides a 45-60% practical range with a maximum around 60% because modules are made to order and require line flush-outs for customer specifications. The gap between cell and module utilisation is deliberate: module capacity is sized above cell capacity so the two stages produce broadly equivalent annual output.

The 6 GW Devanahalli project is the main earnings milestone. Total cost is about INR 5,500 crore, including INR 4,600 crore of hard cost, with INR 3,300 crore of debt tied up at under 8%. All critical equipment is ordered and construction is in full swing; equipment was to be in place by November, the module line is targeted for December 2026 and the cell line for March 2027. By Q2 FY27, INR 828 crore of debt had been drawn and interest was being capitalised until commissioning. Management said 25% state capital subsidy received on the earlier project could be available for upcoming projects but was not included in guidance. The project is not complete, and the commissioning dates are guidance rather than achieved facts.

The order book supports near-term conversion but not the full programme. It stood at 10.4 GW at 30 September 2026, after about 1.5 GW of Q2 inflows, the highest in one quarter. Management said 5-5.5 GW is deliverable in the next 12-15 months, and the order book includes capacity for the upcoming 6 GW expansion. That is enough to keep the current lines and the first phase of the new module line busy, but it does not remove execution risk on the cell line. The 4.5 GW multi-year TOPCon cell order booked in Q3 FY26 provides a base for merchant cell sales, though management has not disclosed the cell-versus-module revenue split.

Management’s FY27 EBITDA guidance is the key near-term test. In July 2026 it targeted approximately INR 2,400 crore. In October 2026, with H1 EBITDA at INR 1,105 crore, it said it could achieve the upper part of a INR 2,200-2,400 crore range discussed by an analyst. Our inference is that the lower end requires roughly flat H2 EBITDA of about INR 1,095 crore, while the upper end requires about INR 1,295 crore, or roughly 17% growth over H1. The upper end therefore depends on the December 2026 module line contributing and on cell utilisation staying near 90%. This is analyst arithmetic, not company guidance.

Capital allocation is disciplined but not risk-free. The 6 GW project is debt-funded at under 8%, with interest capitalised during construction, and the balance sheet still carried net debt to equity of 0.12x at September 2026. The 9 GW ingot and wafer plan is split into 5 GW and 4 GW phases, with timing guided by ALMM List 3, market conditions and long-term viability. Q4 FY26 estimated capex at INR 600-700 crore per GW, funded largely through internal accruals. The project remains optional and is not in current guidance. Until it is built, Emmvee remains exposed to upstream wafer supply and pricing.

Management delivery is mixed but mostly positive. The IPO-funded deleveraging delivered the promised interest saving. Cell utilisation met the 85% lower bound in March 2026 and reached 89% in Q2 FY27. The margin band has held. The 6 GW project is on its stated timeline but has not commissioned. The FY27 EBITDA target is open, and the ingot and wafer plan has no current date. The main falsifiers are a module or cell line slip beyond December 2026 and March 2027, cell utilisation falling below 85%, DCR order conversion stalling, H2 FY27 EBITDA below about INR 1,095 crore, and a customer concentration event around the largest customer at 44% of Q2 revenue. If those do not occur, the operating leverage from a larger cell base and a 70% DCR order book can persist; if they do, the capitalised interest and underutilised module capacity would work in the other direction.

Why is Emmvee Photovoltaic Power Ltd stock rising?

• H1 FY27 EBITDA was INR 1,105 crore on revenue of INR 3,132 crore, with a 35% margin. Management said this positions it to achieve the upper part of the INR 2,200-2,400 crore FY27 EBITDA range discussed by an analyst. The upper end requires H2 EBITDA of about INR 1,295 crore, while the lower end requires about INR 1,095 crore.
• The Devanahalli cell line is targeted for March 2027 and would lift cell capacity from 2.94 GW to 8.9 GW, taking total module capacity to 16.3 GW. Cells earn guided EBITDA per watt of INR 6.0-6.5 versus INR 2.5 for non-DCR modules, so the mix shifts toward the higher-margin product as DCR demand expands under ALMM List 2.
• Q2 FY27 cell utilisation reached 89% and management expects close to 90% for the remaining two quarters. More than 50% of cell capacity had converted to G12R by Q2 FY27, with the remainder to follow after M10 orders. Higher effective capacity raises output without new equipment.
• The order book was 10.4 GW at 30 September 2026 after about 1.5 GW of Q2 inflows, the highest in one quarter. About 70% was DCR and 30% non-DCR, and management said 5-5.5 GW is deliverable in the next 12-15 months. The order book includes capacity for the upcoming 6 GW expansion.
• Management said a deferment of ALMM List 2 beyond December 2026 looked extremely unlikely and described implementation as phased. DCR sales were over 50% in Q1 and Q2 FY27. The domestic TOPCon cell supply remains tight, supporting pricing for compliant cell manufacturers.

Research report

companyname: Emmvee Photovoltaic Power Limited ticker: EMMVEE sector: Solar manufacturing (photovoltaic modules and cells) companyname: Emmvee Photovoltaic Power Limited ticker: EMMVEE sector: Solar manufacturing (photovoltaic modules and cells) Emmvee Photovoltaic Power Limited is an integrated Indian solar manufacturer that started as a solar water heater maker more than three decades ago and now produces TOPCon solar cells and modules. The company listed on BSE and NSE in November 2025, rai...

Catalysts

capex

Growth guidance

Management said H1 FY27 EBITDA of INR 1,105 crore positions it to achieve the upper part of the discussed INR 2,200-2,400 crore FY27 EBITDA guidance. It targets the 6 GW module line by December 2026 and cell line by March 2027, cell utilisation near 90% for the remaining two quarters, module utilisation of 45-60%, and ingot-wafer timing subject to ALMM List 3.

Management consistency

overdeliver